' 
SCIENTIFIC SCORE
Questionable
Based on 3 Researches
5.7
USERS' SCORE
Good
Based on 9 Reviews
8.1
Supplement Facts
Serving Size: 2 Softgels
Amount Per Serving
%DV
Calories
20
Total Fat
2 g
3%**
Saturated Fat
0.5 g
3%**
Polyunsaturated Fat
1 g
†
Monounsaturated Fat
0.5 g
†
Fish Oil Concentrate
2 g (2,000 mg)
†
Eicosapentaenoic Acid (EPA)
360 mg
†
Docosahexaenoic Acid (DHA)
240 mg
†
Top Medical Research Studies
7
Omega-3 benefits IBS-D gut health
Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet.
Relevant to dietary management strategies
We examined how omega-3 fish oil relates to gut health in patients with diarrhea-predominant irritable bowel syndrome (IBS-D). This involved studying 38 individuals who started a low-FODMAP diet for 12 weeks.
Initially, those with a compromised gut barrier displayed lower omega-3 levels. Post-diet, improvements were noted, with higher omega-3 levels and better gut function. This suggests that omega-3 fatty acids play a crucial role in enhancing gut integrity and may aid in managing IBS-D symptoms.
Initially, those with a compromised gut barrier displayed lower omega-3 levels. Post-diet, improvements were noted, with higher omega-3 levels and better gut function. This suggests that omega-3 fatty acids play a crucial role in enhancing gut integrity and may aid in managing IBS-D symptoms.
Read More
5
Fatty acids affect IBS metabolism
Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome.
Limited direct evidence of eicosapentaenoic acid
Our study focused on understanding how eicosapentaenoic acid, alongside other fatty acids, influences irritable bowel syndrome (IBS). We designed an experiment where we treated both maternally separated and non-separated rats with Bifidobacterium breve and explored its effect on colonic sensitivity and fatty acid metabolism over a period of seven weeks.
Throughout our research, we observed significant changes in fatty acid profiles, especially in liver and serum tissues, after administering Bifidobacterium breve. Notably, in the maternally separated rats, the treatment appeared to enhance levels of palmitoleic acid, arachidonic acid, and docosahexaenoic acid in various tissues, which are fatty acids that others believe could be influential in managing symptoms related to IBS.
However, while eicosapentaenoic acid was present in the research context, it was largely studied in combination with other treatments. This made it challenging to evaluate its isolated effect on IBS directly. Thus, while we noted some positive metabolic changes with our treatment approach, the specific impact of eicosapentaenoic acid on IBS symptoms wasn’t definitively established.
Overall, our findings suggest that while Bifidobacterium breve and fatty acid supplementation may influence host fatty acid metabolism, further focused studies are necessary to clarify the role of eicosapentaenoic acid in managing irritable bowel syndrome.
Throughout our research, we observed significant changes in fatty acid profiles, especially in liver and serum tissues, after administering Bifidobacterium breve. Notably, in the maternally separated rats, the treatment appeared to enhance levels of palmitoleic acid, arachidonic acid, and docosahexaenoic acid in various tissues, which are fatty acids that others believe could be influential in managing symptoms related to IBS.
However, while eicosapentaenoic acid was present in the research context, it was largely studied in combination with other treatments. This made it challenging to evaluate its isolated effect on IBS directly. Thus, while we noted some positive metabolic changes with our treatment approach, the specific impact of eicosapentaenoic acid on IBS symptoms wasn’t definitively established.
Overall, our findings suggest that while Bifidobacterium breve and fatty acid supplementation may influence host fatty acid metabolism, further focused studies are necessary to clarify the role of eicosapentaenoic acid in managing irritable bowel syndrome.
Read More
5
DHA effects on IBS unclear
Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome.
Combination treatment explored, limited findings
We aimed to understand the role of docosahexaenoic acid (DHA) in the context of irritable bowel syndrome (IBS) by investigating how it works alongside Bifidobacterium breve and essential fatty acids, namely α-linolenic acid and linoleic acid.
Our study involved maternally separated and non-separated rats, who received different dietary supplements for a period of seven weeks. We specifically looked for changes in colonic sensitivity and fatty acid profiles in various tissues, comparing supplemented and control groups.
The results showed that feeding B. breve to maternally separated rats notably increased levels of palmitoleic acid, arachidonic acid, and DHA in their liver, along with adjustments in other fatty acids within brain and body fat tissues. However, the same supplementation in non-separated rats elevated other fatty acids, with a significant boost in eicosapentaenoic acid and docosapentaenoic acid in their serum.
Overall, while we observed that DHA levels adjusted in response to the supplementations, the specific effects of DHA on IBS symptoms remain unclear, especially since it was administered in combination with other treatments. This indicates that more focused research on DHA alone is necessary to fully gauge its impact on IBS.
Our study involved maternally separated and non-separated rats, who received different dietary supplements for a period of seven weeks. We specifically looked for changes in colonic sensitivity and fatty acid profiles in various tissues, comparing supplemented and control groups.
The results showed that feeding B. breve to maternally separated rats notably increased levels of palmitoleic acid, arachidonic acid, and DHA in their liver, along with adjustments in other fatty acids within brain and body fat tissues. However, the same supplementation in non-separated rats elevated other fatty acids, with a significant boost in eicosapentaenoic acid and docosapentaenoic acid in their serum.
Overall, while we observed that DHA levels adjusted in response to the supplementations, the specific effects of DHA on IBS symptoms remain unclear, especially since it was administered in combination with other treatments. This indicates that more focused research on DHA alone is necessary to fully gauge its impact on IBS.
Read More
Most Useful Reviews
8.3
Better bowel function
Unlike other companies' Omega-3 supplements, these do not have a fishy smell and are easy to swallow. I’ve noticed lesser skin issues before my period and improved bowel movements. This is my second purchase, and I will repurchase once I finish.
Read More
8.8
Reduced stress symptoms
My husband and I had COVID-19 and are recovering. We take a complex of vitamins and Omega-3. My husband's headaches have diminished, and he no longer reacts to the weather. We consume two capsules daily, and I've noticed improved physical activity and stress levels. Omega-3 is beneficial for cardiovascular health, restoring vascular elasticity and reducing cholesterol levels. It also strengthens the immune system during colds and helps mitigate various health issues, including symptoms of irritable bowel syndrome.
Read More
9
Enhanced bowel regularity
Since I started taking this product, my bowel movements have improved greatly. While it may seem unnecessary if you consume fish regularly, I find it beneficial as I do not eat fish often.
Read More
Medical Researches
SCIENTIFIC SCORE
Questionable
Based on 3 Researches
5.7
- All Researches
7
Omega-3 benefits IBS-D gut health
Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet.
Relevant to dietary management strategies
We examined how omega-3 fish oil relates to gut health in patients with diarrhea-predominant irritable bowel syndrome (IBS-D). This involved studying 38 individuals who started a low-FODMAP diet for 12 weeks.
Initially, those with a compromised gut barrier displayed lower omega-3 levels. Post-diet, improvements were noted, with higher omega-3 levels and better gut function. This suggests that omega-3 fatty acids play a crucial role in enhancing gut integrity and may aid in managing IBS-D symptoms.
Initially, those with a compromised gut barrier displayed lower omega-3 levels. Post-diet, improvements were noted, with higher omega-3 levels and better gut function. This suggests that omega-3 fatty acids play a crucial role in enhancing gut integrity and may aid in managing IBS-D symptoms.
Read More
5
Fatty acids affect IBS metabolism
Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome.
Limited direct evidence of eicosapentaenoic acid
Our study focused on understanding how eicosapentaenoic acid, alongside other fatty acids, influences irritable bowel syndrome (IBS). We designed an experiment where we treated both maternally separated and non-separated rats with Bifidobacterium breve and explored its effect on colonic sensitivity and fatty acid metabolism over a period of seven weeks.
Throughout our research, we observed significant changes in fatty acid profiles, especially in liver and serum tissues, after administering Bifidobacterium breve. Notably, in the maternally separated rats, the treatment appeared to enhance levels of palmitoleic acid, arachidonic acid, and docosahexaenoic acid in various tissues, which are fatty acids that others believe could be influential in managing symptoms related to IBS.
However, while eicosapentaenoic acid was present in the research context, it was largely studied in combination with other treatments. This made it challenging to evaluate its isolated effect on IBS directly. Thus, while we noted some positive metabolic changes with our treatment approach, the specific impact of eicosapentaenoic acid on IBS symptoms wasn’t definitively established.
Overall, our findings suggest that while Bifidobacterium breve and fatty acid supplementation may influence host fatty acid metabolism, further focused studies are necessary to clarify the role of eicosapentaenoic acid in managing irritable bowel syndrome.
Throughout our research, we observed significant changes in fatty acid profiles, especially in liver and serum tissues, after administering Bifidobacterium breve. Notably, in the maternally separated rats, the treatment appeared to enhance levels of palmitoleic acid, arachidonic acid, and docosahexaenoic acid in various tissues, which are fatty acids that others believe could be influential in managing symptoms related to IBS.
However, while eicosapentaenoic acid was present in the research context, it was largely studied in combination with other treatments. This made it challenging to evaluate its isolated effect on IBS directly. Thus, while we noted some positive metabolic changes with our treatment approach, the specific impact of eicosapentaenoic acid on IBS symptoms wasn’t definitively established.
Overall, our findings suggest that while Bifidobacterium breve and fatty acid supplementation may influence host fatty acid metabolism, further focused studies are necessary to clarify the role of eicosapentaenoic acid in managing irritable bowel syndrome.
Read More
5
DHA effects on IBS unclear
Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome.
Combination treatment explored, limited findings
We aimed to understand the role of docosahexaenoic acid (DHA) in the context of irritable bowel syndrome (IBS) by investigating how it works alongside Bifidobacterium breve and essential fatty acids, namely α-linolenic acid and linoleic acid.
Our study involved maternally separated and non-separated rats, who received different dietary supplements for a period of seven weeks. We specifically looked for changes in colonic sensitivity and fatty acid profiles in various tissues, comparing supplemented and control groups.
The results showed that feeding B. breve to maternally separated rats notably increased levels of palmitoleic acid, arachidonic acid, and DHA in their liver, along with adjustments in other fatty acids within brain and body fat tissues. However, the same supplementation in non-separated rats elevated other fatty acids, with a significant boost in eicosapentaenoic acid and docosapentaenoic acid in their serum.
Overall, while we observed that DHA levels adjusted in response to the supplementations, the specific effects of DHA on IBS symptoms remain unclear, especially since it was administered in combination with other treatments. This indicates that more focused research on DHA alone is necessary to fully gauge its impact on IBS.
Our study involved maternally separated and non-separated rats, who received different dietary supplements for a period of seven weeks. We specifically looked for changes in colonic sensitivity and fatty acid profiles in various tissues, comparing supplemented and control groups.
The results showed that feeding B. breve to maternally separated rats notably increased levels of palmitoleic acid, arachidonic acid, and DHA in their liver, along with adjustments in other fatty acids within brain and body fat tissues. However, the same supplementation in non-separated rats elevated other fatty acids, with a significant boost in eicosapentaenoic acid and docosapentaenoic acid in their serum.
Overall, while we observed that DHA levels adjusted in response to the supplementations, the specific effects of DHA on IBS symptoms remain unclear, especially since it was administered in combination with other treatments. This indicates that more focused research on DHA alone is necessary to fully gauge its impact on IBS.
Read More
User Reviews
USERS' SCORE
Good
Based on 9 Reviews
8.1
- All Reviews
- Positive Reviews
- Negative Reviews
8.3
Better bowel function
Unlike other companies' Omega-3 supplements, these do not have a fishy smell and are easy to swallow. I’ve noticed lesser skin issues before my period and improved bowel movements. This is my second purchase, and I will repurchase once I finish.
8.8
Reduced stress symptoms
My husband and I had COVID-19 and are recovering. We take a complex of vitamins and Omega-3. My husband's headaches have diminished, and he no longer reacts to the weather. We consume two capsules daily, and I've noticed improved physical activity and stress levels. Omega-3 is beneficial for cardiovascular health, restoring vascular elasticity and reducing cholesterol levels. It also strengthens the immune system during colds and helps mitigate various health issues, including symptoms of irritable bowel syndrome.
Read More
9
Enhanced bowel regularity
Since I started taking this product, my bowel movements have improved greatly. While it may seem unnecessary if you consume fish regularly, I find it beneficial as I do not eat fish often.
8.5
Improved bowel movements
My bowel movements have improved significantly, and I feel much better after using the toilet. Overall, this has had a positive effect on my skin and blood.
7.5
Consistent bowel improvement
If taken consistently, this supplement significantly helps with bowel movements.
